A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
INDEX TO BUSINESS Business Segments U.S. Pharmaceutical Prescription Technology Solutions Medical-Surgical Solutions Investments, Restructuring, Business Combinations, and Divestitures Patents, Trademarks, Copyrights, and Licenses Human Capital Government Regulation Other Information about the Business Forward-Looking Statements McKesson Corporation together with its subsidiaries (collectively, the “Company,” “McKesson,” “we,” “our,” or “us” and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company’s fiscal year begins on April 1 and ends on March 31.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 398.0B | 359.1B | 309.0B | 276.7B | 264.0B | 238.2B |
| Net Income | 4.3B | 3.3B | 3.0B | 3.6B | 1.1B | -4.5B |
| EPS | $34.65 | $25.72 | $22.39 | $25.03 | $7.23 | $-28.26 |
| Free Cash Flow | 10.0B | 5.5B | 3.9B | 4.8B | 4.0B | 4.1B |
| ROIC | 963.9% | 5.0% | 4.8% | 5.7% | 2.2% | -6.1% |
| Gross Margin | 3.6% | 3.7% | 4.2% | 4.5% | 5.0% | 5.1% |
| Debt/Equity | 0.00 | -4.14 | -3.77 | -4.45 | -3.67 | -375.71 |
| Dividends/Share | $3.03 | $2.75 | $2.40 | $2.09 | $1.83 | $1.67 |
| Operating Income | 5.7B | 4.4B | 3.9B | 4.4B | 2.0B | -5.0B |
| Operating Margin | 1.4% | 1.2% | 1.3% | 1.6% | 0.8% | -2.1% |
| ROE | 0.0% | -162.9% | -152.3% | -191.7% | -49.0% | - |
| Shares Outstanding | 122M | 128M | 134M | 142M | 154M | 161M |
MCKESSON CORP passes 5 of 9 quality checks, suggesting mixed fundamentals.
MCKESSON CORP trades at 25.0x trailing earnings, compared to its 15-year median P/E of 23.8x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 10.6x vs a median of 8.9x. The company's 5-year average ROIC is 2.3% with a gross margin of 4.5%. Total shareholder yield (dividends + buybacks) is 2.6%. At current prices, the estimated annualized return to fair value is +12.3%.
MCKESSON CORP (MCK) has a current P/E ratio of 25.0, compared to its historical median P/E of 23.8. The stock is currently considered Fair based on its historical valuation range.
MCKESSON CORP (MCK) has a 5-year average return on invested capital (ROIC) of 2.3%. This is below average and may indicate limited pricing power.
MCKESSON CORP (MCK) has a market capitalization of $105.9B. It is classified as a large-cap stock.
Yes, MCKESSON CORP (MCK) pays a dividend with a trailing twelve-month yield of 0.35%. The company also returns capital through share buybacks, with a buyback yield of 2.25%.
Based on historical P/E analysis, MCKESSON CORP (MCK) appears fair. The current P/E of 25.0 is 5% above its historical median of 23.8. The estimated fair value CAGR (P/E method) is 100.7%.
MCKESSON CORP (MCK) operates in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, within the Consumer Defensive sector.
MCKESSON CORP (MCK) reported annual revenue of $359.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
MCKESSON CORP (MCK) has a net profit margin of 0.9%. This is a modest margin.
MCKESSON CORP (MCK) generated $5.5 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
MCKESSON CORP (MCK) reported earnings per share (EPS) of $25.72 in its most recent fiscal year.
MCKESSON CORP (MCK) has a return on equity (ROE) of -162.9%. A negative ROE may indicate losses or negative equity.
MCKESSON CORP (MCK) has a 5-year average gross margin of 4.5%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 18 years of financial data for MCKESSON CORP (MCK), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
MCKESSON CORP (MCK) has a book value per share of $-16.19, based on its most recent annual SEC filing.
No recent press releases.